Sale!

KCNQ3 Gene Seizures Benign Neonatal Type 2 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The KCNQ3 Gene Seizures Benign Neonatal Type 2 NGS Genetic DNA Test is a specialized genetic analysis that identifies mutations in the KCNQ3 gene associated with benign familial neonatal seizures. This comprehensive test utilizes Next Generation Sequencing technology to detect specific genetic variants that cause neonatal-onset seizure disorders. The test is crucial for infants experiencing unexplained seizures during the first weeks of life, helping to differentiate between benign familial conditions and more serious neurological disorders. With results available in 3-4 weeks, this test provides valuable information for treatment planning and genetic counseling. The test is priced at $500 USD (regularly $700 USD) and requires a simple blood sample or extracted DNA. Our genetic specialists provide thorough pre-test counseling and detailed result interpretation to guide families through the diagnostic process.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

KCNQ3 Gene Seizures Benign Neonatal Type 2 NGS Genetic DNA Test

Comprehensive Genetic Testing for Neonatal Seizure Disorders

The KCNQ3 Gene Seizures Benign Neonatal Type 2 NGS Genetic DNA Test represents a breakthrough in pediatric neurological genetic diagnostics. This advanced test specifically targets mutations in the KCNQ3 gene, which plays a critical role in potassium channel function and neuronal excitability regulation. Benign familial neonatal seizures type 2 is an autosomal dominant inherited condition characterized by brief seizures occurring in otherwise healthy newborns during the first days to weeks of life.

What This Test Measures and Detects

Our comprehensive NGS-based genetic analysis examines the entire coding region of the KCNQ3 gene to identify:

  • Point mutations affecting potassium channel function
  • Missense mutations disrupting neuronal membrane stability
  • Frameshift mutations altering protein structure
  • Copy number variations affecting gene dosage
  • Specific variants associated with benign neonatal seizure type 2

Who Should Consider This Genetic Test

This specialized genetic testing is recommended for:

  • Newborns experiencing unexplained seizures within the first month of life
  • Infants with family history of neonatal seizure disorders
  • Patients with suspected benign familial neonatal epilepsy
  • Individuals with recurrent seizures despite normal development
  • Families seeking genetic counseling for inheritance patterns

Clinical Symptoms and Indications

Common clinical presentations that warrant KCNQ3 genetic testing include:

  • Brief, recurrent seizures in otherwise healthy newborns
  • Seizures typically lasting 1-2 minutes
  • Normal interictal neurological examination
  • Family history of similar neonatal seizure patterns
  • Absence of metabolic or structural brain abnormalities

Benefits of KCNQ3 Genetic Testing

Undergoing this specialized genetic analysis provides numerous advantages for patients and families:

  • Accurate Diagnosis: Differentiate between benign familial conditions and more serious neurological disorders
  • Treatment Guidance: Inform appropriate anti-epileptic medication selection
  • Genetic Counseling: Provide accurate recurrence risk information for family planning
  • Prognostic Information: Understand the typically favorable long-term outcome
  • Early Intervention: Enable timely management and monitoring strategies

Understanding Your Test Results

Our comprehensive genetic counseling services help you interpret your KCNQ3 test results:

  • Positive Result: Indicates presence of a pathogenic KCNQ3 mutation, confirming diagnosis of benign familial neonatal seizures type 2
  • Negative Result: Suggests absence of detectable KCNQ3 mutations, though other genetic causes should be considered
  • Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications requiring further evaluation
  • Carrier Status: Determines inheritance patterns for family members

Test Pricing and Details

Test Component Details
Test Name KCNQ3 Gene Seizures Benign Neonatal Type 2 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next Generation Sequencing (NGS) Technology

Pre-Test Requirements

Before scheduling your KCNQ3 genetic test, we require:

  • Complete clinical history of the patient
  • Genetic counseling session with our specialists
  • Detailed pedigree chart of family members affected with similar conditions
  • Neurological evaluation documentation

Nationwide Testing Availability

We provide comprehensive KCNQ3 genetic testing services across the United States with convenient locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, and many more. Our network of certified genetic counselors and neurologists ensures you receive expert care regardless of your location.

Book Your Genetic Test Today

Take the first step toward understanding your genetic health. Our team of genetic specialists is ready to guide you through the testing process and provide comprehensive result interpretation. Contact us today to schedule your appointment and begin your journey to genetic clarity.

Call or WhatsApp: +1(267) 388-9828

Don’t wait to get the answers you need about neonatal seizure disorders. Our advanced NGS technology and expert genetic counseling provide the comprehensive analysis required for accurate diagnosis and informed treatment decisions.